Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1 Advanced treatment for Osteoarthritis
  • Track 1-2Osteoarthritis affecting Cartilage
  • Track 1-3Natural remedies for Osteoarthritis
  • Track 2-1Ligament reconstruction
  • Track 2-2Interpositional reconstruction
  • Track 2-3Resurfacing arthroplasty
  • Track 2-4Mold arthroplasty
  • Track 2-5Cup arthroplasty
  • Track 2-6Knee arthroplasty
  • Track 2-7Hip Arthoplasty
  • Track 2-8Silicone replacement arthroplasty
  • Track 3-1Soft Tissue Rheumatism
  • Track 3-2Pharmacological Treatment of AS
  • Track 3-3Rheumatic fever
  • Track 3-4Pediatric Rheumatology
  • Track 3-5Inflammatory Rheumatism
  • Track 3-6Degenerative arthropathies
  • Track 3-7Systemic conditions and connective tissue diseases
  • Track 4-1Lyme disease
  • Track 4-2Ankylosing spondylitis
  • Track 4-3Gout and Pseudo Gout
  • Track 4-4Sarcoidosis
  • Track 4-5Behcet Disease
  • Track 4-6Sclerodoma
  • Track 4-7Vasculitis
  • Track 4-8Sjogren Syndrome
  • Track 4-9Tendinitis and Bursitis
  • Track 4-10Polymyalgia Rheumatica
  • Track 4-11Inflammatory Myositis
  • Track 4-12Systemic lupus erythematosus (SLE)
  • Track 5-1Mixed Connective Tissue Disease
  • Track 5-2Serum Sickness
  • Track 5-3Golfers Elbow
  • Track 5-4Beurger Disease
  • Track 5-5Myofascial Pain
  • Track 5-6Scurvy
  • Track 6-1Systemic lupus erythematosus (SLE)
  • Track 6-2Clinical Features of Systemic lupus erythematosus
  • Track 6-3Discoid lupus erythematosus
  • Track 6-4Subacute cutaneous lupus erythematosus
  • Track 6-5Drug-induced lupus
  • Track 6-6Neonatal lupus
  • Track 7-1Ankylosing spondylitis (AS) and cardiovascular disease
  • Track 7-2Diagnosis of Ankylosing spondylitis Treatment of AS
  • Track 7-3Non pharmacological therapies for AS Clinical trials on AS
  • Track 8-1Fibromyalgia pain treatment
  • Track 8-2Pathophysiological basis for chronic pain in Fibromyalgia
  • Track 8-3Recent Advances in the Treatment of Fibromyalgia
  • Track 8-4Future perspective regarding fibromyalgia
  • Track 9-1• Present Research on Pain Management in Rheumatic Conditions
  • Track 9-2Future Perspectives
  • Track 9-3Effective management of Pain Management
  • Track 9-4Pharmacological treatment
  • Track 9-5Non-pharmacological therapies
  • Track 9-6Interventional therapies
  • Track 10-1Arthroplasty and total joint reconstruction
  • Track 10-2Joint and knee replacement treatment
  • Track 10-3Biologic agents and therapies for Rheumatoid Arthritis
  • Track 10-4Disease-modifying anti Rheumatic drugs
  • Track 10-5Immunological treatment of Rheumatic Disorders
  • Track 10-6Physiotherapeutic treatments and advances
  • Track 10-7Physiotherapy Instruments
  • Track 11-1Inflammatory Arthritis
  • Track 11-2Mechanical Arthritis
  • Track 11-3Connective Tissue Disease
  • Track 11-4Infectious Arthritis
  • Track 11-5Metabolic Arthritis
  • Track 11-6Post-Traumatic Knee Arthritis
  • Track 11-7Fibromyalgia
  • Track 11-8Septic Arthritis
  • Track 11-9Gout
  • Track 11-10Advance treatment of Arthritis
  • Track 11-11Pharmacological treatment of Arthritis
  • Track 11-12Herbal Treatment of Arthritis
  • Track 11-13Natural Remedies of Arthritis
  • Track 12-1Sign and symptoms of Rheumatic Arthritis
  • Track 12-2Risk factor of Rheumatic Arthritis
  • Track 12-3Juvenile Rheumatoid Arthritis
  • Track 12-4Application of TNF α and IL-1 drugs in Rheumatic Arthritis
  • Track 12-5Treatments of Rheumatic Arthritis
  • Track 12-6Pharmacological Treatment of RA
  • Track 12-7Non-pharmacological treatment of RA
  • Track 12-8Emerging therapies
  • Track 12-9Gene array analysis in Rheumatic Arthritis